Okadaic acid induced neurotoxicity: An emerging tool to study Alzheimer's disease pathology

被引:115
作者
Kamat, Pradip K. [1 ]
Rai, Shivika [2 ]
Nath, Chandishwar [2 ]
机构
[1] Univ Louisville, Div Physiol & Biophys, Sch Med, Louisville, KY 40202 USA
[2] Cent Drug Res Inst, Div Pharmacol, Lucknow 226001, Uttar Pradesh, India
关键词
Okadaic acid; Alzheimer's disease; Neurotoxicity; REGULATES TAU PHOSPHORYLATION; SPATIAL MEMORY IMPAIRMENT; PROTEIN PHOSPHATASE 2A; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; RECEPTOR TRAFFICKING; CHOLINERGIC NEURONS; INDUCED MODEL; CELL-DEATH; A-BETA;
D O I
10.1016/j.neuro.2013.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Okadaic acid (OKA) is one of the main polyether toxins produced by marine microalgae which causes diarrhetic shellfish poisoning. It is a selective and potent inhibitor of serine/threonine phosphatases 1 and 2A induces hyperphosphorylation of tau in vitro and in vivo. The reduced activity of phosphatases like, protein phosphatase 2A (PP2A) has been implicated in the brain of Alzheimer's disease (AD) patients. It is reported that AD is a complex multifactorial neurodegenerative disorder and hyperphosphorylated tau proteins is a major pathological hallmark of AD. The molecular pathogenesis of AD includes an extracellular deposition of beta amyloid (A beta), accumulation of intracellular neurofibrillary tangles (NFT), GSK3 beta activation, oxidative stress, altered neurotransmitter and inflammatory cascades. Several lines of evidence suggested that the microinfusion of OKA into the rat brain causes cognitive deficiency, NFTs-like pathological changes and oxidative stress as seen in AD pathology via tau hyperphosphorylation caused by inhibition of protein phosphatases. So, communal data and information inferred that OKA induces neurodegeneration along with tau hyperphosphorylation; GSK3 beta activation, oxidative stress, neuroinflammation and neurotoxicity which is a characteristic feature of AD pathology. Through this collected evidence, it is suggested that OKA induced neurotoxicity may be a novel tool to study Alzheimer's disease pathology and helpful in development of new therapeutic approach. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 130 条
[1]  
Abraha A, 2000, J CELL SCI, V113, P3737
[2]   Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis [J].
Ahn, Kook-Hee ;
Kim, Young-Sun ;
Kim, Seon-Ye ;
Huh, Youngbuhm ;
Park, Chan ;
Jeong, Loo-Won .
NEUROSCIENCE LETTERS, 2009, 449 (02) :93-97
[3]  
ARIAS C, 1993, J NEUROCHEM, V61, P673
[4]   The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo [J].
Arias, C ;
Becerra-García, F ;
Arrieta, I ;
Tapia, R .
EXPERIMENTAL NEUROLOGY, 1998, 153 (02) :242-254
[5]   Tau-mediated neurodegeneration in Alzheimer's disease and related disorders [J].
Ballatore, Carlo ;
Lee, Virginia M. -Y. ;
Trojanowski, John Q. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) :663-672
[6]   Microtubule Stabilizing Agents as Potential Treatment for Alzheimer's Disease and Related Neurodegenerative Tauopathies [J].
Ballatore, Carlo ;
Brunden, Kurt R. ;
Huryn, Donna M. ;
Trojanowski, John Q. ;
Lee, Virginia M. -Y. ;
Smith, Amos B., III .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (21) :8979-8996
[7]   Novel effects on memory observed following unilateral intracranial administration of okadaic acid, cyclosporin A, FK506 and [MeVal4]CyA [J].
Bennett, PC ;
Moutsoulas, P ;
Lawen, A ;
Perini, E ;
Ng, KT .
BRAIN RESEARCH, 2003, 988 (1-2) :56-68
[8]   Concentration-dependent effects of protein phosphatase (PP) inhibitors implicate PP1 and PP2A in different stages of memory formation [J].
Bennett, PC ;
Zhao, WQ ;
Ng, KT .
NEUROBIOLOGY OF LEARNING AND MEMORY, 2001, 75 (01) :91-110
[9]   INHIBITORY EFFECT OF A MARINE-SPONGE TOXIN, OKADAIC ACID, ON PROTEIN PHOSPHATASES - SPECIFICITY AND KINETICS [J].
BIALOJAN, C ;
TAKAI, A .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :283-290
[10]   Tau, tangles, and Alzheimer's disease [J].
Binder, LI ;
Guillozet-Bongaarts, AL ;
Garcia-Sierra, F ;
Berry, RW .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3) :216-223